임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
24건 표시
- 1/2상모집 예정· B-cell Acute Lymphoblastic LeukemiaA Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
협력: 암젠, 화이자
- 1/2상모집 중· Urothelial CancerSymbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
리드: 화이자
- 1/2상모집 중· Advanced/Metastatic Non-Small Cell Lung CancerSymbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
리드: 화이자
- 1/2상모집 중· Carcinoma, HepatocellularSymbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
리드: 화이자
- 1/2상모집 중· Breast CancerA Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
리드: 화이자
- 1/2상모집 중· Obesity and Obesity-related Medical ConditionsA Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
리드: 화이자
- 1/2상모집 중단 (진행 중)· Breast CancerA Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.
리드: 화이자
- 1/2상모집 중단 (진행 중)· Pulmonary Arterial HypertensionA Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
리드: 화이자
- 1/2상모집 중단 (진행 중)· Clostridoides Difficile Associated DiseaseTo Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults
리드: 화이자
- 1/2상모집 중· Endometrial CancerA Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
협력: 일라이 릴리, 화이자, 로슈
- 1/2상모집 중· Recurrent Solid TumorStudy of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
협력: 화이자
- 1/2상모집 중· Acute Myeloid LeukemiaCombination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)
협력: 노바티스, 화이자
- 1/2상모집 중단 (진행 중)· Philadelphia Chromosome Positive CMLBosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia
협력: 화이자
- 1/2상모집 중단 (진행 중)· Breast CancerStudy to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.
협력: 화이자
- 1/2상모집 중단 (진행 중)· TNBC - Triple-Negative Breast CancerGedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers
협력: 화이자
- 1/2상모집 중단 (진행 중)· Breast CancerTALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer
협력: 화이자
- 1/2상모집 중· Metastatic Breast CancerA Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
리드: 로슈 · 협력: 길리어드, 화이자
- 1/2상모집 중단 (진행 중)· HPV-Related CarcinomaPhase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
협력: 화이자
- 1/2상모집 중단 (진행 중)· Metastatic Breast Cancer (MBC)Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)
협력: 화이자
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.